Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
Booking.com
BKNG
$111B
| $3.31M | ﹤0.01% |
18,593
-771,382
| -98% | -$132M |
2013 Q2
52 quarters
|
|
927
FTI Consulting
FCN
$4.98B
| $3.29M | ﹤0.01% |
22,086
-4,924
| -18% | -$806K |
2013 Q2
52 quarters
|
|
928
York Space Systems
YSS
$868M
| $3.28M | ﹤0.01% |
133,200
-155,300
| -54% | -$4.82M |
2026 Q1
1 quarter
|
|
929
MetLife
MET
$63.6B
| $3.23M | ﹤0.01% |
38,126
-4,442
| -10% | -$358K |
2013 Q2
52 quarters
|
|
930
CBIZ
CBZ
$3.02B
| $3.21M | ﹤0.01% |
+100,099
| New | +$3.11M |
2026 Q2
0 quarters
|
|
931
Kforce
KFRC
$1.03B
| $3.19M | ﹤0.01% |
67,963
+3,156
| +5% | +$129K |
2015 Q3
43 quarters
|
|
932
Peoples Bancorp
PEBO
$1.39B
| $3.15M | ﹤0.01% |
82,035
+4,629
| +6% | +$161K |
2016 Q2
40 quarters
|
|
933
Jones Lang LaSalle
JLL
$16.4B
| $3.14M | ﹤0.01% |
10,137
+1,675
| +20% | +$521K |
2013 Q2
52 quarters
|
|
934
US Foods
USFD
$22.4B
| $3.12M | ﹤0.01% |
30,473
-1,069
| -3% | -$95.4K |
2021 Q4
18 quarters
|
|
935
Western New England Bancorp
WNEB
$277M
| $3.08M | ﹤0.01% |
215,685
+587
| +0.3% | +$8.02K |
2017 Q1
37 quarters
|
|
936
FIGS
FIGS
$3.54B
| $3.05M | ﹤0.01% |
298,621
+116,125
| +64% | +$1.53M |
2026 Q1
1 quarter
|
|
937
Avista
AVA
$3.15B
| $3.04M | ﹤0.01% |
74,305
-9,423
| -11% | -$388K |
2024 Q3
7 quarters
|
|
938
Midland States Bancorp
MSBI
$683M
| $3.03M | ﹤0.01% |
97,322
+39,627
| +69% | +$1.07M |
2016 Q4
38 quarters
|
|
939
Tutor Perini Cor
TPC
$4.2B
| $3.01M | ﹤0.01% |
36,338
+35,927
| +8,741% | +$2.89M |
2025 Q2
4 quarters
|
|
940
Immunome
IMNM
$2.15B
| $3.01M | ﹤0.01% |
+142,097
| New | +$3.04M |
2026 Q2
0 quarters
|
|
941
Biohaven
BHVN
$2.33B
| $3.01M | ﹤0.01% |
+202,040
| New | +$2.17M |
2026 Q2
0 quarters
|
|
942
Haemonetics
HAE
$5.44B
| $2.99M | ﹤0.01% |
39,928
-123
| -0.3% | -$7.9K |
2015 Q4
42 quarters
|
|
943
Red Rock Resorts
RRR
$2.91B
| $2.99M | ﹤0.01% |
46,028
+17,007
| +59% | +$968K |
2019 Q2
28 quarters
|
|
944
The Southern Company 2025 Series A Corp Units
SOMN
| $2.98M | ﹤0.01% |
60,000
| – | – |
2025 Q4
2 quarters
|
|
945
Merit Medical Systems
MMSI
$5.17B
| $2.98M | ﹤0.01% |
43,010
+9,622
| +29% | +$635K |
2024 Q1
9 quarters
|
|
946
4D Molecular Therapeutics
FDMT
$657M
| $2.96M | ﹤0.01% |
222,416
-1,209,844
| -84% | -$11.8M |
2024 Q4
6 quarters
|
|
947
ICF International
ICFI
$1.71B
| $2.92M | ﹤0.01% |
40,034
-1,153
| -3% | -$79.6K |
2022 Q2
16 quarters
|
|
948
Septerna Inc
SEPN
$2.05B
| $2.91M | ﹤0.01% |
86,753
-2,548
| -3% | -$72.3K |
2025 Q4
2 quarters
|
|
949
Block Inc
XYZ
$45.8B
| $2.88M | ﹤0.01% |
37,913
+37,576
| +11,150% | +$2.64M |
2020 Q2
24 quarters
|
|
950
Zillow
ZG
$7.17B
| $2.88M | ﹤0.01% |
91,808
+45,718
| +99% | +$1.77M |
2022 Q2
16 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.